Thank you for joining Purple Innovation's fourth-quarter 2024 earnings call. A copy of our earnings press release is available on the Investor Relations section of Purple's website at Before we begin ...

Purple Innovation Inc (PRPL) reports improved margins and EBITDA profitability amid revenue declines, focusing on strategic ...

Q4 2024 and Recent Clinical & Corporate Highlights ... in research and development expenses. As of December 31, 2024, Purple Biotech had cash and cash equivalents and short-term deposits of ...

Our major value-driving milestones in 2024 included completing successful trials for both of our clinical-stage programs, CM24 and NT219, as ...

Video streaming platform Rumble Inc (NASDAQ:RUM) is likely to highlight new growth initiatives like Rumble Live and its ...

Financially, Purple Biotech reported decreased operating losses for both the fourth quarter and entire year of 2024, with a cash runway projected until mid-2026. Completed successful clinical ...

The industrial Royal Purple business is a great business with ... The WCS differential in Rocky Mountain fuel cracks softened during Q4 2024, reflecting both asphalt and fuels regional seasonality ...